Scientists caution that a rare childhood liver cancer can spread to the brain

March 14, 2018, Rockefeller University
Credit: Rockefeller University

Early detection is key for managing metastatic brain cancer. Above, a secondary brain tumor originating from melanoma skin cancer.

A surprising finding by Rockefeller University scientists about a rare liver cancer's behavior could lead to more comprehensive patient monitoring and hopefully better outcomes.

The scientists recommend that people with advanced-stage fibrolamellar hepatocellular carcinoma, which mostly affects teenagers and young adults, receive regular neuroimaging scans because of the tumor's apparent ability to metastasize to the brain. Solid tumors, including those in the liver, don't usually spread to the brain, so scans to monitor fibrolamellar patients' progress typically don't include the head.

Earlier detection of brain metastases could increase the chances of successful surgical removal of the tumors, says Sanford Simon, whose Laboratory of Cellular Biophysics previously identified the genetic driver behind fibrolamellar. It also could help clinicians to make more informed choices about what drugs to use.

Only a minority of fibrolamellar patients will develop , Simon expects. Still, testing for that possibility is important when a 's spread can have such severe consequences. About 200 cases of fibrolamellar are reported worldwide each year, though Simon believes the disease is underdiagnosed. Only about one in three patients survive beyond five years.

In a paper published recently in the journal Pediatric Blood & Cancer, he and colleagues document three cases in which fibrolamellar patients, all 18-year-old women, were found to have developed brain tumors. Cranial scans were performed only after the patients developed symptoms including severe headaches and changes in mental status. The tumors had also metastasized to the lungs of the three patients, one of whom had died when the paper was published.

Metastasis is common with fibrolamellar, partly because the disease isn't usually detected until it is at an advanced stage. Early symptoms, such as , could have many causes, and doctors may first check adolescent patients for issues such as stress or lactose intolerance.

Simon suggests that clinicians perform an ultrasound when teens complain about abdominal pain over an extended period, at least to rule out cancer.

The finding that fibrolamellar can spread to the doesn't immediately add to scientists' understanding of the biology of the disease, Simon says, but is nevertheless significant as it may offer immediate ways to improve treatment. Meanwhile, his team is working to develop a cure for fibrolamellar that acts by directly targeting the genetic driver of the disease. In other investigations, they are seeking to identify biomarkers in the blood that could lead to earlier detection of fibrolamellar and better tracking of patients' progress after tumors are surgically removed.

Another way Simon and his colleagues are trying to help more immediately is through extensive testing of existing drug compounds that have already been assessed for human safety. This could yield more effective chemotherapies for fibrolamellar in the near future, he says.

Explore further: Gene mutation associated with development of fibrolamellar hepatocellular carcinoma

More information: William J. Hammond et al, Intracranial metastasis in fibrolamellar hepatocellular carcinoma, Pediatric Blood & Cancer (2017). DOI: 10.1002/pbc.26919

Related Stories

Gene mutation associated with development of fibrolamellar hepatocellular carcinoma

February 28, 2014
In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Teen helps scientists study her own rare disease

February 27, 2014
(AP)—First the American teenager survived a rare cancer. Then she wanted to study it, spurring a study that helped scientists find a weird gene flaw that might play a role in how the tumor strikes.

Researchers working on blood test to detect brain metastases while still treatable

August 4, 2017
Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response ...

Cause of cancer form in the liver identified

October 12, 2017
In a new study, researchers from the University of Copenhagen have identified the two genes whose mutation cause a serious cancer form found in the liver. The result sets concrete goals for future treatment of the otherwise ...

New study shows targeted therapy needed for breast cancer with brain metastases

December 7, 2016
Researchers at the University of Pittsburgh Cancer Institute (UPCI) and Magee-Womens Research Institute (MWRI) have discovered molecular changes in the primary tumor of breast cancer patients who developed brain metastases. ...

Recommended for you

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

New treatment helps avoid deafness in child chemotherapy patients

June 21, 2018
An international trial has found that a medicine commonly used to treat poisoning is effective in reducing deafness in children receiving chemotherapy for cancer.

New therapeutic opportunity for the treatment of resistant malignant melanoma

June 21, 2018
A team of researchers led by Dr. Pierre Close, WELBIO researcher at the ULiège GIGA Institute and Dr. Francesca Rapino has uncovered a new therapeutic opportunity in the treatment of malignant melanoma that has acquired ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.